Gene: FBLN7
Official Full Name: fibulin 7provided by HGNC
Gene Summary: Predicted to enable calcium ion binding activity; heparan sulfate proteoglycan binding activity; and heparin binding activity. Predicted to be involved in cell adhesion. Located in focal adhesion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26657 | FBLN7 Knockout cell line (HeLa) | Human | FBLN7 | 1:3~1:6 | Negative | Online Inquiry |
FBLN7 Gene Knockout Cell Lines are highly specialized cellular models engineered to lack the functional expression of the fibulin-7 (FBLN7) gene. This gene is implicated in various biological processes, including cell adhesion, tissue remodeling, and the regulation of extracellular matrix components. By utilizing CRISPR-Cas9 technology, these knockout cell lines provide researchers with robust tools to investigate the multifaceted roles of FBLN7 in cellular biology and disease pathology, including its contributions to cancer progression and tissue repair mechanisms.
The primary function of FBLN7 Gene Knockout Cell Lines lies in their ability to facilitate the study of gene function and molecular pathways. Without FBLN7, researchers can examine the resultant phenotypic changes, such as altered cell migration, proliferation, and differentiation, thereby providing insights into the gene's role in various physiological and pathological contexts. These cell lines serve as valuable resources for dissecting signaling pathways and genetic interactions, thereby enhancing the understanding of tumor microenvironments and innovative therapeutic targets.
The scientific importance of FBLN7 Gene Knockout Cell Lines is underscored by their potential applications in basic research and drug development. Researchers can employ these models to elucidate the mechanisms underpinning diseases linked to dysregulation of FBLN7, assisting in the identification of novel biomarkers for prognostic purposes. Clinically, the insights gained can pave the way for targeted therapies, making FBLN7 an appealing candidate for further exploration in oncological and regenerative medicine.
What sets FBLN7 Gene Knockout Cell Lines apart from traditional cell lines is their precision and specificity. These models offer a streamlined method for studying gene function without the confounding variables present in less defined systems. They enable reproducibility and detailed analysis, essential for advancing knowledge in biomedical research.
For researchers and clinicians focused on uncovering the complexities of cellular behaviors and therapeutic approaches, FBLN7 Gene Knockout Cell Lines represent an invaluable tool to dissect gene function and foster the development of innovative treatments. Our company, a leader in genomic technologies and cellular biology solutions, is dedicated to providing exceptional biological products that empower scientific discovery and innovation in health sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.